Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Q1 2021 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

Jul 31, 2020 / 09:30AM GMT
Release Date Price: $18.2 (+0.22%)
Operator

Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. (Operator Instructions)

Now we start the conference. Mr. Okubo, please go ahead.

Takashi Okubo
Takeda Pharmaceutical Company Limited - Global Head of IR, Global Finance

[Interpreted] Thank you very much for coming to join in FY 2020 Q1 earnings announcement. I'd like to serve us a facilitator today of Global IR Head. In this conference call, 1995 U.S. Litigation Reform Act (sic) [Private Securities Litigation Reform Act of 1995], the forward-looking statement and related informations will be discussed. And the results of discussions may differ substantially from the actual results. And the latest Form 20-F and other SEC-submitted documents describe all those potential factors. And in Page 2 of today's presentations, there are important notice discussed. Please also refer to that page.

And we have presenters and the responders to your questions. We have Christophe Weber, President and CEO; Chief Financial Officer, Costa Saroukos; Avanti President,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot